Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case–Control Study

(2015) Pär Stattin et al.   EUROPEAN UROLOGY

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

(2015) Laurence Klotz et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score

(2015) Kimberly A. Herget et al.   Cancer Medicine

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Prostate cancer risk prediction based on complete prostate cancer family history

(2014) Frederick Albright et al.   PROSTATE

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013)   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness Review: Prostate Cancer Antigen 3 Testing for the Diagnosis and Management of Prostate Cancer

(2013) Linda A. Bradley et al.   JOURNAL OF UROLOGY

A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate cancer

(2013) Quentin Nelson et al.   Frontiers in Genetics

Systematic, evidence-based discovery of biomarkers at the NCI

(2012) John R. Prensner et al.   CLINICAL & EXPERIMENTAL METASTASIS

The Role of Genetic Markers in the Management of Prostate Cancer

(2012) Atish D. Choudhury et al.   EUROPEAN UROLOGY

Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: Longitudinal study

(2011) Mattias Johansson et al.   INTERNATIONAL JOURNAL OF CANCER

The use of PCA3 in the diagnosis of prostate cancer

(2009) Daphne Hessels et al.   Nature Reviews Urology